Jan 30 (Reuters) - Cigna Group CI.N:
Q4 ADJUSTED REVENUE $65.68 BILLION VERSUS IBES ESTIMATE $63.36 BILLION
Q4 ADJUSTED EPS $6.64 VERSUS IBES ESTIMATE $7.82
Q4 MEDICAL CARE RATIO 87.9% VERSUS IBES ESTIMATE 84.84%
OUTLOOK FY ADJUSTED EPS AT LEAST $29.50 VERSUS IBES ESTIMATE $31.50
OUTLOOK FY ADJUSTED REVENUE AT LEAST $252 BILLION VERSUS IBES ESTIMATE $251.95 BILLION
HIGHER MEDICAL COSTS IN STOP LOSS PRODUCT IMPACTED Q4; TAKING ACTIONS TO ADDRESS NEAR-TERM PRESSURES
RAISES QTRLY DIVIDEND 8% TO $1.51/SHARE, APPROVED INCREASE OF $6 BILLION IN SHARE BUYBACKS
Source text: [ID:]
Further company coverage: CI.N
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。